Publicaciones en las que colabora con MARÍA AURORA ARRUE ULLES (26)

2023

  1. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment

    Pharmaceutics, Vol. 15, Núm. 8

2022

  1. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder

    Clinical Psychology and Psychotherapy, Vol. 29, Núm. 2, pp. 501-511

2021

  1. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter

    Schizophrenia Research, Vol. 228, pp. 382-384

  2. Lithium: An old treatment for a new indication

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 3, pp. 125-127

2020

  1. Episodios repetidos de psicosis de inicio tardío asociados a efavirenz

    Actas Espanolas de Psiquiatria

  2. Genetic modulation of facial emotion recognition in borderline personality disorder

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99

2019

  1. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels

    Neurochemistry International, Vol. 124, pp. 152-161

2017

  1. Mania preceding pancreatic cancer

    Actas espanolas de psiquiatria, Vol. 45, Núm. 1, pp. 39-46

  2. Manía y cáncer de páncreas

    Actas Espanolas de Psiquiatria

2016

  1. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

2013

  1. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients

    PLoS ONE, Vol. 8, Núm. 4

2012

  1. Aripiprazole reverses Paliperidoneinduced Hyperprolactinemia

    Actas Espanolas de Psiquiatria, Vol. 40, Núm. 5, pp. 290-292

2011

  1. Variability of plasma homovanillic acid over 13 months in patients with Schizophrenia; Relationship with the clinical response and the wisconsin card sort test

    Neurochemical Research, Vol. 36, Núm. 8, pp. 1336-1343

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779

  2. Factores biológicos en el diagnostico diferencial de los trastornos bipolares

    Avances en salud mental relacional, Vol. 6, Núm. 3

  3. GABA and homovanillic acid in the plasma of schizophrenic and bipolar i patients

    Neurochemical Research, Vol. 35, Núm. 2, pp. 247-253

2009

  1. Diagnóstico "adyuvantivus" y terapia electroconvulsiva: a propósito de un caso

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 16, Núm. 3, pp. 131-133

  2. Efecto paradójico del tratamiento con aripiprazol en un paciente bipolar: de la psicofarmacología a la psicopatología

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 16, Núm. 2, pp. 94-96

  3. Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients

    Pharmacological Research, Vol. 59, Núm. 4, pp. 269-272

2008

  1. Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder

    Neuropsychobiology, Vol. 58, Núm. 3-4, pp. 111-117